News Release

Association of SARS-CoV-2 vaccination or infection with Bell palsy

JAMA Otolaryngology–Head & Neck Surgery

Peer-Reviewed Publication

JAMA Network

About The Study: This systematic review and meta-analysis suggests a higher incidence of Bell palsy (BP) among SARS-CoV-2–vaccinated versus placebo groups. The occurrence of BP did not differ significantly between recipients of the Pfizer/BioNTech versus Oxford/AstraZeneca vaccines. SARS-CoV-2 infection posed a significantly greater risk for BP than SARS-CoV-2 vaccination. 

Authors: Amir Kheradmand, M.D., of Johns Hopkins University in Baltimore, and Mehran Rahimlou, Ph.D., of the Zanjan University of Medical Sciences in Zanjan, Iran, are the corresponding authors. 

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamaoto.2023.0160)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

#  #  #

Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaotolaryngology/fullarticle/10.1001/jamaoto.2023.0160?guestAccessKey=3757267f-e10c-4a3e-8db5-5118cb8d7944&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=042723


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.